Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.03)
# 542
Out of 5,143 analysts
352
Total ratings
42.61%
Success rate
15.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $29.64 | +68.69% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $4.57 | +162.58% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $332.85 | +71.25% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $7.99 | +400.63% | 17 | Aug 4, 2025 | |
| ATAI AtaiBeckley | Maintains: Buy | $10 → $15 | $4.37 | +243.25% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $19.32 | -48.24% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.69 | +195.86% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.47 | +2,016.40% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.33 | +1,307.13% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $33.68 | +196.91% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $24.03 | +191.30% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.13 | +342.48% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.00 | +1,400.00% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $63.67 | +25.65% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $15.29 | +161.61% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.78 | +693.65% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $28.19 | +148.32% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $32.29 | +147.75% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.74 | +474.71% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.42 | +2,307.32% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $9.49 | +1,059.11% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $89.09 | -4.59% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $11.12 | +511.51% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $75.34 | +351.29% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $29.64
Upside: +68.69%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $4.57
Upside: +162.58%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $332.85
Upside: +71.25%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $7.99
Upside: +400.63%
AtaiBeckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.37
Upside: +243.25%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $19.32
Upside: -48.24%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.69
Upside: +195.86%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.47
Upside: +2,016.40%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $5.33
Upside: +1,307.13%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $33.68
Upside: +196.91%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $24.03
Upside: +191.30%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.13
Upside: +342.48%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.00
Upside: +1,400.00%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $63.67
Upside: +25.65%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $15.29
Upside: +161.61%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $3.78
Upside: +693.65%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $28.19
Upside: +148.32%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $32.29
Upside: +147.75%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.74
Upside: +474.71%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.42
Upside: +2,307.32%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $9.49
Upside: +1,059.11%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $89.09
Upside: -4.59%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $11.12
Upside: +511.51%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $75.34
Upside: +351.29%